# Single Cell Analysis Reveals Dynamic Changes of Distinct Cell Populations in Human Nickel Allergy

**Authors:** Marc Schmidt, Andrea Knorz, Katharina Meder, Simon Goller, Fabian Imdahl, Yamila Rocca, Matthias Goebeler, Pierre Khoueiry

PMC · DOI: 10.1111/all.70108 · Allergy · 2025-10-15

## TL;DR

This study uses single-cell RNA sequencing to identify cell types involved in early and late immune responses in human nickel allergy.

## Contribution

The study identifies distinct cell populations and molecular pathways involved in the early and late phases of nickel hypersensitivity in human skin.

## Key findings

- Early hypersensitivity involves TLR4+ endothelial cells, suprabasal keratinocytes, and CCR7+ dendritic cells.
- Late hypersensitivity is marked by infiltration of KLF2+ central memory T cells and TLR4+CD163+CCR7− DC3 cells.
- Skin-resident T cells do not contribute to the early response but change significantly after 72 hours.

## Abstract

Metal allergies are prime examples of delayed‐type hypersensitivity divided into two phases: in the sensitization phase, initial contact with an allergen leads to activation of skin‐resident cells and formation of metal‐reactive T cells. during elicitation, these T cells mount an immune response resulting in clinically apparent eczema within 72 h after exposure. Two main mechanisms have been implicated in the initiation of metal hypersensitivity: direct or indirect activation of innate immune receptors such as Toll‐like receptor 4, and conditional innate immune activation via the NLRP3 inflammasome. Yet, the responsible cell type(s) mediating these responses are unknown. Moreover, it is unclear whether the elicitation phase is mainly dominated by infiltration of circulating metal‐responsive T cells or if tissue‐resident T cells contribute.

Here, we analyzed the relevance of different cell types in human nickel hypersensitivity by single‐cell RNA sequencing and immunofluorescence analysis of skin samples of nickel‐sensitized donors epicutaneously exposed to diluent and nickel for 8 or 72 h.

Nickel specifically activated distinct populations of endothelial cells, suprabasal keratinocytes, fibroblasts, and 
CCR7


+
 dendritic cells, co‐expressing the TLR4‐interacting proteogylcan 
DCN
 and CCR7 ligand 
CCL21
 within 8 h. Skin‐resident T cells were not involved in the early hypersensitivity response, as their gene expression remained unaltered 8 h after nickel exposure. However, substantial changes in the cutaneous T cell compartments occurred after 72 h, with massive infiltration of KLF2
+ central memory T cells being a recurrent feature of both nickel‐sensitized patients and individuals allergic to the glucocorticoid contact allergen budesonide.

We investigated cell types mediating the early and late inflammatory responses in human Ni2+‐allergy by scRNA‐Seq. Early responsiveness was mainly mediated by TLR4+TAGLN− endothelial cells indirectly activating TLR4−KRT16+ keratinocytes, and CCR7+DCN+ DCs. Late responsiveness was crucially driven by infiltration of KLF2+ central memory T cells and TLR4+CD163+CCR7− DC3 cells. CCR7, C‐C chemokine receptor type 7; DC, dendritic cells; EC, endothelial cells; IF, immunofluorescence; KC, keratinocytes; KLF2, Krüppel‐like factor 2; Ni2+, nickel; scRNA‐Seq, single cell RNA sequencing; SELL, L‐selectin; TAGLN, transgelin; TCM, central memory T cell; Th, T helper cell; TLR4, Toll‐like receptor 4.

## Linked entities

- **Genes:** TLR4 (toll like receptor 4) [NCBI Gene 7099], CCR7 (C-C motif chemokine receptor 7) [NCBI Gene 1236], DCN (decorin) [NCBI Gene 1634], CCL21 (C-C motif chemokine ligand 21) [NCBI Gene 6366], KLF2 (KLF transcription factor 2) [NCBI Gene 10365], KRT16 (keratin 16) [NCBI Gene 3868], TAGLN (transgelin) [NCBI Gene 6876], CD163 (CD163 molecule) [NCBI Gene 9332], SELL (selectin L) [NCBI Gene 6402]
- **Chemicals:** nickel (PubChem CID 935), budesonide (PubChem CID 5281004)
- **Diseases:** eczema (MONDO:0004980)

## Full-text entities

- **Genes:** DCN (decorin) [NCBI Gene 1634] {aka CSCD, DSPG2, PG40, PGII, PGS2, SLRR1B}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, KLF2 (KLF transcription factor 2) [NCBI Gene 10365] {aka LKLF}, CCL21 (C-C motif chemokine ligand 21) [NCBI Gene 6366] {aka 6Ckine, CKb9, ECL, SCYA21, SLC, TCA4}, CCR7 (C-C motif chemokine receptor 7) [NCBI Gene 1236] {aka BLR2, CC-CKR-7, CCR-7, CD197, CDw197, CMKBR7}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}
- **Diseases:** allergies (MESH:D004342), eczema (MESH:D004485)
- **Chemicals:** budesonide (MESH:D019819), Nickel (MESH:D009532), Metal (MESH:D008670)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13040661/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13040661/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC13040661/full.md

---
Source: https://tomesphere.com/paper/PMC13040661